share_log

Smart Money Is Betting Big In MRK Options

Smart Money Is Betting Big In MRK Options

聰明的投資者正在大量購買MRk期權
Benzinga ·  07/25 15:46

Financial giants have made a conspicuous bearish move on Merck & Co. Our analysis of options history for Merck & Co (NYSE:MRK) revealed 9 unusual trades.

默沙東遭遇金融巨頭明顯看淡,我們對默沙東(NYSE:MRK)期權歷史的分析發現了9筆飛凡交易。

Delving into the details, we found 44% of traders were bullish, while 55% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $123,625, and 6 were calls, valued at $299,194.

詳細了解後,我們發現44%的交易者看漲,而55%的交易行爲呈現看淡趨勢。在我們發現交易中,3筆爲看跌期權,價值$123,625,6筆爲看漲期權,價值$299,194。

Projected Price Targets

預計價格目標

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $120.0 to $130.0 for Merck & Co during the past quarter.

在這些合約中分析成交量和持倉量,似乎大型交易者在過去一季度眼中盯着默沙東在$120.0至$130.0的價位區間。

Analyzing Volume & Open Interest

分析成交量和未平倉合約

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Merck & Co's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Merck & Co's substantial trades, within a strike price spectrum from $120.0 to $130.0 over the preceding 30 days.

評估成交量和持倉量是期權交易中的一個戰略性步驟。這些指標闡明瞭在特定行權價的情況下,投資者在默沙東期權上的流動性和興趣。即將發佈的數據將展示在先前30天內默沙東在$120.0至$130.0的行權價範圍內,與看漲看跌期權相聯繫的成交量和持倉量的波動。

Merck & Co Call and Put Volume: 30-Day Overview

默沙東的看漲和看跌成交量:30天概述

1721936764_0.png

Significant Options Trades Detected:

檢測到重大期權交易:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
MRK CALL SWEEP BULLISH 07/26/24 $3.9 $3.7 $3.85 $124.00 $73.5K 443 214
MRK CALL SWEEP BEARISH 08/02/24 $3.1 $3.0 $3.0 $127.00 $60.0K 300 226
MRK CALL SWEEP BULLISH 09/20/24 $9.7 $9.7 $9.7 $120.00 $55.2K 1.9K 60
MRK PUT TRADE BULLISH 07/26/24 $0.43 $0.33 $0.35 $125.00 $51.9K 1.6K 4.0K
MRK CALL SWEEP BEARISH 08/02/24 $3.05 $3.0 $3.05 $127.00 $45.7K 300 193
標的 看跌/看漲 交易類型 情緒 到期日 賣盤 買盤 價格 執行價格 總交易價格 未平倉合約數量 成交量
MRK 看漲 SWEEP 看好 07/26/24 $3.9 $3.7 $3.85 $124.00 $73.5K 443 214
MRK 看漲 SWEEP 看淡 08/02/24 $3.1 $3.0 $3.0 $127.00 $60.0K 300 226
MRK 看漲 SWEEP 看好 09/20/24 9.7 9.7 9.7 $120.00 $55.2K 1.9K 60
MRK 看跌 交易 看好 07/26/24 $0.43 $0.33 $0.35 $125.00 $51.9K 1.6K 4.0K
MRK 看漲 SWEEP 看淡 08/02/24 $3.05 $3.0 $3.05 $127.00 45700美元 300 193

About Merck & Co

關於默沙東

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

默沙東生產多種藥品,治療多種領域的疾病,包括心代謝症、癌症和感染。在癌症領域,該公司的免疫腫瘤學平台正在成爲總銷售額的主要貢獻者。該公司還具有實質性的疫苗業務,包括預防兒童疾病以及人類乳頭瘤病毒(HPV)治療。此外,默沙東出售與動物健康相關的藥品。從地理角度來看,公司銷售額的近一半來自於美國境內。

After a thorough review of the options trading surrounding Merck & Co, we move to examine the company in more detail. This includes an assessment of its current market status and performance.

對於默沙東周圍的期權交易進行全面審查後,我們開始更詳細地審查該公司的情況。這包括對其當前市場地位和表現的評估。

Present Market Standing of Merck & Co

默沙東的現市場地位

  • Trading volume stands at 4,941,230, with MRK's price up by 0.4%, positioned at $126.42.
  • RSI indicators show the stock to be is currently neutral between overbought and oversold.
  • Earnings announcement expected in 5 days.
  • 交易量爲4,941,230,MRK的價格上漲了0.4%,位於$126.42。
  • RSI指標顯示該股票目前處於超買和超賣之間的中立狀態。
  • 預計5天內將公佈業績報告。

What The Experts Say On Merck & Co

默沙東公司專家們的觀點

A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $134.0.

過去30天中,共有1位專業分析師對這隻股票進行了評估,並設定了一個平均價格目標爲$134.0。

  • An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Merck & Co, which currently sits at a price target of $134.
  • 大摩資源lof的一位分析師決定維持對默沙東的等權重評級,當前價格目標爲$134。

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Merck & Co with Benzinga Pro for real-time alerts.

期權交易涉及更大的風險,但也提供了更高的利潤潛力。精明的交易者通過持續教育、戰略性交易調整、利用各種因子和關注市場動態來降低這些風險。使用 Benzinga Pro 獲取默沙東的最新期權交易實時警報。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論